Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
This study has been terminated.
( The study was truncated due to the long period of enrollment and the collection of a sufficient amount of data that allowed the scientific objectives to be met )
Study NCT00327197
Information provided by GlaxoSmithKline
First Received on May 17, 2006.
Last Updated on December 19, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
